Treatment of mycosis fungoides with brentuximab vedotin: assessing CD30 expression by immunohistochemistry and quantitative real‐time PCR

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/cup.14178.

留言 (0)

沒有登入
gif